Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Jamie L. Reynoso is CEO, Medicare Advantage at Clover Health Investments, Corp.. OQRO lists 9 transactions filed with the SEC under this name, the latest on Oct 20, 2026, each linked to the official Form 4.
CEO, Medicare Advantage
Disclosures on record
9
Companies involved
1
Clover Health Investments, Corp.CLOV
9 disclosures · Jun 2025 – Oct 2026 · 9 sold
Oct 19, 2026Sold~$18Kdisclosed Oct 20
DetailsOfficial recordOct 15, 2026Sold~$86Kdisclosed Oct 19
DetailsOfficial recordOct 7, 2026Sold~$9.3K
DetailsOfficial recordOct 5, 2026Sold~$39Kdisclosed Oct 6
DetailsOfficial recordSep 17, 2025Sold~$15Kdisclosed Sep 19
DetailsOfficial recordAug 4, 2025Sold~$20Kdisclosed Aug 6
DetailsOfficial recordJul 3, 2025Sold~$51Kdisclosed Jul 8
DetailsOfficial recordJul 7, 2025Sold~$5.7Kdisclosed Jul 8
DetailsOfficial recordJun 17, 2025Sold~$58Kdisclosed Jun 18
DetailsOfficial recordJamie L. Reynoso has no open-market purchase on record since 2025. Sales in 2 of the 2 years since 2025.
Jamie L. Reynoso reported 0 open-market purchases and 9 sales since 2025; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $151K4×4 trades |
| 2025 | — | $150K5×5 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , Jamie L. Reynoso reported holding 2,770,351 shares of Clover Health Investments, Corp. (CLOV), worth about $11.6M at the last close of $4 (Nov 18, 2026). In the last 12 months, Jamie L. Reynoso sold $151K in 4 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. CLOV | 2,770,351 | 2.77M direct | $4 | $11.6M | Oct 19, 2026 |
Is this Jamie L. Reynoso’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Oct 19, 2026, Jamie L. Reynoso reported holding 2,770,351 shares of Clover Health Investments, Corp. (CLOV). At the last close of $4 on Nov 18, 2026, that is about $11.6M. This is the stake disclosed in filings, not a net worth.
No public filing gives Jamie L. Reynoso's net worth. What SEC Form 4 shows is the stock stake: 2,770,351 shares of Clover Health Investments, Corp. (CLOV), about $11.6M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, Jamie L. Reynoso reported 4 open-market sales worth $151K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Jamie L. Reynoso has no open-market purchase on record since 2025. Sales in 2 of the 2 years since 2025.
In SEC filings since 2025: no open-market purchase is on record; the latest open-market sale is from 2026.
Clover Health Investments, Corp. (CLOV), from 2025 to 2026: 0 purchases and 9 sales.
Jamie L. Reynoso reported 0 open-market purchases and 9 sales here, 2025 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.